🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research will study safety and the body's immune (defense system) resp...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-06
Trial ID
NCT00912496
Treatments Being Tested
The present study will evaluate the immunogenicity, safety and immunogenici...
Status
Completed
Location
Vaccination and Travel Medicine Centre
Start Date
2008-11
Trial ID
NCT00848029
Treatments Being Tested
This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Status
Completed
Location
Optimal Research, LLC
Start Date
2016-07-11
Trial ID
NCT02839330
This BARDA-sponsored, randomized, double-blind, phase 2 study is designed t...
Status
Completed
Location
DelRicht Research - Atlanta
Start Date
2024-08-21
Trial ID
NCT06560151
Treatments Being Tested
Evaluate the safety, immune response and reactogenicity of aH5N1 vaccinatio...
Status
Completed
Location
102, Novartis Investigational Site
Start Date
2014-04
Trial ID
NCT02107807
The present study, phase III, randomized, controlled, observer-blind, multi...
Status
Completed
Location
Tampere Vaccine Research Clinic (15 sites)
Start Date
2008-10
Trial ID
NCT00841763
Valuate the immune response and reactogenicity of H5N1 vaccination in a pri...
Status
Completed
Location
Infectious Diseases Unit
Start Date
2007-05
Trial ID
NCT00478816
Treatments Being Tested
This study focuses on pre-pandemic priming of man against H5 influenza with...
Status
Completed
Location
University Hospitals Leicester
Start Date
2008-11
Trial ID
NCT00814385
Treatments Being Tested
This is a Phase 2, randomized, multi-center study in approximately 300 adul...
Status
Completed
Location
Optimal Research, LLC
Start Date
2022-07-18
Trial ID
NCT05422326
Treatments Being Tested
This is a Phase II randomized, partially-blinded, controlled trial in 360 (...
Status
Completed
Location
Emory Vaccine Center - The Hope Clinic
Start Date
2014-10
Trial ID
NCT02213354
Treatments Being Tested